04/26/2024
5:16 AM | Reneo Pharmaceuticals (Filer)
| Form 10-K/A | |
03/28/2024
3:05 PM | Reneo Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:00 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Reneo Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
3:01 PM | Octagon Capital Advisors LP (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13G | |
12/26/2023
4:00 PM | Reneo Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13D | |
12/15/2023
3:55 PM | Novo Holdings A/S (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13D/A | |
|
12/14/2023
8:26 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
11/13/2023
3:58 PM | Reneo Pharmaceuticals (Filer)
| Form 424B5 | |
11/13/2023
4:08 PM | Reneo Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/30/2023
3:47 PM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:08 AM | Reneo Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
4:04 PM | Hall Ashley (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
4:33 PM | Hall Ashley (Reporting)
Reneo Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/27/2023
4:16 PM | GREY MICHAEL G (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
6:10 PM | Novo Holdings A/S (Reporting)
Reneo Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
6:15 PM | Novo Holdings A/S (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
11:15 PM | Reneo Pharmaceuticals (Filer)
| Form EFFECT | |
06/08/2023
7:09 PM | Mathers Edward T (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:02 PM | Dube Eric M (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:06 PM | Reneo Pharmaceuticals (Issuer)
Seltzer Stacey Denenberg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:13 PM | O'Donnell Niall (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:14 PM | Muralidhar Bali (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:15 PM | Hoelscher Paul W. (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:16 PM | GREY MICHAEL G (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:17 PM | Blunt Roshawn A. (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:47 PM | O'Donnell Niall (Reporting)
Reneo Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
3:31 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Reneo Pharmaceuticals (Subject)
| Form SC 13D/A | |
